These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 17878328)
1. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype. Gary-Gouy H; Sainz-Perez A; Marteau JB; Marfaing-Koka A; Delic J; Merle-Beral H; Galanaud P; Dalloul A J Immunol; 2007 Oct; 179(7):4335-44. PubMed ID: 17878328 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70. Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235 [TBL] [Abstract][Full Text] [Related]
3. Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex. Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; O'Brien S; Bose P; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z Mol Cancer Res; 2017 May; 15(5):610-618. PubMed ID: 28130399 [TBL] [Abstract][Full Text] [Related]
4. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients. Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858 [TBL] [Abstract][Full Text] [Related]
5. CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes. Garaud S; Taher TE; Debant M; Burgos M; Melayah S; Berthou C; Parikh K; Pers JO; Luque-Paz D; Chiocchia G; Peppelenbosch M; Isenberg DA; Youinou P; Mignen O; Renaudineau Y; Mageed RA Cell Mol Immunol; 2018 Feb; 15(2):158-170. PubMed ID: 27499044 [TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935 [TBL] [Abstract][Full Text] [Related]
8. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation. Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617 [TBL] [Abstract][Full Text] [Related]
9. CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells. Chunsong H; Yuling H; Li W; Jie X; Gang Z; Qiuping Z; Qingping G; Kejian Z; Li Q; Chang AE; Youxin J; Jinquan T J Immunol; 2006 Nov; 177(10):6713-22. PubMed ID: 17082584 [TBL] [Abstract][Full Text] [Related]
10. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. Frank DA; Mahajan S; Ritz J J Clin Invest; 1997 Dec; 100(12):3140-8. PubMed ID: 9399961 [TBL] [Abstract][Full Text] [Related]
11. Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. Hahn M; Bürckert JP; Luttenberger CA; Klebow S; Hess M; Al-Maarri M; Vogt M; Reißig S; Hallek M; Wienecke-Baldacchino A; Buch T; Muller CP; Pallasch CP; Wunderlich FT; Waisman A; Hövelmeyer N Leukemia; 2018 Jan; 32(1):72-82. PubMed ID: 28566736 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation. Hammadi A; Billard C; Faussat AM; Kolb JP Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259 [TBL] [Abstract][Full Text] [Related]
13. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia. Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134 [TBL] [Abstract][Full Text] [Related]
19. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Tibaldi E; Brunati AM; Zonta F; Frezzato F; Gattazzo C; Zambello R; Gringeri E; Semenzato G; Pagano MA; Trentin L Leukemia; 2011 Nov; 25(11):1768-81. PubMed ID: 21701493 [TBL] [Abstract][Full Text] [Related]
20. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]